JPRN-UMIN000002791
Completed
Phase 2
Phase II trial of adjuvant chemotherapy with modified medication of S-1 for pancreatic cancer - Phase II trial of adjuvant chemotherapy with S-1 for pancreatic cancer
Conditionspancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- pancreatic cancer
- Sponsor
- Kyoto University Hospital
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Watery diarrhea 2\)Severe mental disorder 3\)Active infection 4\)Severe complications, such as ileus, heart failure and renal failure 5\)Symptomatic pulmonary fibrosis or interstitial pneumonia 6\)History of severe anaphylaxies 7\)Marked pleural or peritoneal effusion 8\)Active concomitant malignancy 9\)Treatment with phenytoin, potassium warfarin or flucytosine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancerpancreatic cancerJPRN-UMIN000017715Osaka University Hospital10
Unknown
Phase 2
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25
Recruiting
Not Applicable
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
Recruiting
Phase 2
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
Completed
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancerJPRN-UMIN000002636Hyogo Cancer Center40